Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00848042 · ClinicalTrials.gov registry record · NA

Pilot Study of AuroLase(tm) Therapy in Refractory and/or Recurrent Tumors of the Head and Neck

A NA study of Head and Neck Cancer, sponsored by Nanospectra Biosciences.

Completed
Registry status
NA
Development phase
11
Enrollment target
2
Study locations

NCT00848042 is a NA study of Head and Neck Cancer that has completed, run by Nanospectra Biosciences. The registered enrollment target is 11 participants, below the 261-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (96% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00848042, a NA study of Head and Neck Cancer, has completed, sponsored by Nanospectra Biosciences.

COMPLETED
Registry status
NA
Development phase
11 participants
Enrollment target
2
Study locations

Study Summary

This is an open-label, multicenter, single-dose pilot study of AuroLase(TM) Therapy in the treatment of patients with refractory and/or recurrent tumors of the head and neck. Three (3) treatment groups of five (5) patients each will be enrolled and observed for six (6) months following treatment. Each group will receive a single dose of AuroShell(TM) particles followed by one or more interstitial illuminations with an 808nm laser. Particle dose and laser power may be increased in each dosing group.

Conditions Studied

Head and Neck Cancer

Interventions

  • DEVICE AuroLase Therapy

Study Locations (2)

Arizona

  • Cancer Treatment Centers of American Western Regional Medical Center - Goodyear

Texas

  • Baylor College of Medicine - Houston

Trial Details

FieldValue
Enrollment Target 11 participants
Start Date 2008-04
Est. Completion 2014-08
Phase NA

Sponsor

Nanospectra Biosciences

3 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00848042

The ClinicalTrials.gov registry entry for NCT00848042 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 261-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (96% lower). The listed sponsor is Nanospectra Biosciences, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Head and Neck Cancer appearing as the primary indexed condition, and to 1 intervention - of which AuroLase Therapy is the first listed.

NCT00848042 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Arizona, Texas.

Frequently Asked Questions

What is clinical trial NCT00848042 about?

NCT00848042 is a clinical study titled "Pilot Study of AuroLase(tm) Therapy in Refractory and/or Recurrent Tumors of the Head and Neck". This is an open-label, multicenter, single-dose pilot study of AuroLase(TM) Therapy in the treatment of patients with refractory and/or recurrent tumors of the head and neck. Three (3) treatment groups of five (5) patients each will be enrolled and observed for six (6) months following treatment. Ea...

What is the current status of trial NCT00848042?

This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2008-04. Estimated completion is 2014-08.

What conditions does trial NCT00848042 study?

This clinical trial studies the following conditions: Head and Neck Cancer.

What interventions are being tested in trial NCT00848042?

The interventions under investigation include: AuroLase Therapy (DEVICE).

Who is sponsoring clinical trial NCT00848042?

This trial is sponsored by Nanospectra Biosciences, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00848042 being conducted?

This trial has 2 study locations across Arizona, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Head and Neck Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Head and Neck Cancer

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.